Amedica granted extension to meet Nasdaq compliance
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Amedica Corp. was granted additional time to regain compliance with the Nasdaq Capital Market's listing requirements.
The medical-grade ceramics manufacturer now has until Oct. 31 to meet the exchange's filing requirement and until Nov. 30 to meet its $1 closing bid price requirement.
Amedica received the noncompliance notice Aug. 22.
